Cost-effective market access strategy for medical technologies in Europe
A holistic approach to reimbursement strategies trusted by global market leaders and SMEs
Recent news and posts
Two more health apps obtained reimbursement in Germany
In March 2023, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by sickness funds.
On March 5, 2023, the "priovi - digitale Unterstützung der Borderline-Behandlung" health app, developed by GAIA AG, Germany, was introduced. "priovi - digitale Unterstützung der Borderline-Behandlung is a web-based health app for patients with a borderline personality disorder with manifestant disease and who are at least 18 years old. The health app conveys methods and exercises from cognitive behavioral therapy and, in this context, builds on the techniques of schema therapy. The app is available in German with a tariff of €855.82.
The "Novego: Ängste überwinden" reimbursable health app, developed by IVPNetworks GmbH, Germany, was introduced in the Directory on March 24, 2023. "Novego: Ängste überwinden" is an online psychological support program for people suffering from anxiety. The program is based on the methods of cognitive behavioral therapy, which are individually tailored to the anxiety symptoms of the participants. The content is prepared in a comprehensible and creative way and presented in a varied way in the form of texts, videos, audios, and interactive exercises. The app is available in German with a tariff of €219.98.
The full details in German can be found here (priovi - digitale Unterstützung der Borderline-Behandlung) and here (Novego: Ängste überwinden).
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.